Compare Alcon AG (ALC) vs Eni SpA (E) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Eni SpA — how do they compare? Alcon AG trades at $66.88 (market cap $32.69B), while Eni SpA trades at $48.39 (market cap $67.72B). The key difference: Eni SpA is far larger — about 2.1× Alcon AG's market cap, and Eni SpA pays the higher dividend (5.25%). Which is the better fit depends on your goals.
| ALC | E | |
|---|---|---|
Market Cap | $32.69B | $67.72B |
Sector | Health | Energy |
52-Week High | $92.22 | $57.61 |
52-Week Low | $62.02 | $32.93 |
Enterprise Value | $36.28B | $86.63B |
Dividend Yield | 0.54% | 5.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Eni (E) trades at $47.47, up 1.28% with a bearish technical signal despite recent earnings beats. The company shows stable cash flow generation with $13.33B operating cash flow in 2025 and maintains a reasonable valuation with P/E of 20.51 and P/S of 0.75. Recent strategic moves include lithium investments in Chile and fusion energy partnerships, signaling diversification beyond traditional energy operations.
While analyst consensus leans neutral (61.53% hold), Eni's transition strategy and global expansion present long-term opportunities. Key risks include declining revenue trends from $132.5B in 2022 to $82.15B in 2025 and competitive pressures in the energy sector. The stock offers value characteristics with dividend income potential amid ongoing business transformation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Eni SpA
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude
Read more on E →
